Advertisement

Loading...

MetaVia Inc.

MTVANASDAQ
Healthcare
Biotechnology
$1.28
$0.11(9.40%)
U.S. Market is Open • 13:35

MetaVia Inc. Fundamental Analysis

MetaVia Inc. (MTVA) shows weak financial fundamentals with a PE ratio of -0.22, profit margin of 0.00%, and ROE of -2.02%. The company generates N/A in annual revenue with weak year-over-year growth of 0.00%.

Key Strengths

Cash Position371.05%
PEG Ratio-0.01
Current Ratio1.93

Areas of Concern

ROE-2.02%
Operating Margin0.00%
We analyze MTVA's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -183.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-183.1/100

We analyze MTVA's fundamental strength across five key dimensions:

Efficiency Score

Weak

MTVA struggles to generate sufficient returns from assets.

ROA > 10%
-18.77%

Valuation Score

Excellent

MTVA trades at attractive valuation levels.

PE < 25
-0.22
PEG Ratio < 2
-0.01

Growth Score

Weak

MTVA faces weak or negative growth trends.

Revenue Growth > 5%
0.00%
EPS Growth > 10%
-9.76%

Financial Health Score

Excellent

MTVA maintains a strong and stable balance sheet.

Debt/Equity < 1
0.04
Current Ratio > 1
1.93

Profitability Score

Weak

MTVA struggles to sustain strong margins.

ROE > 15%
-202.17%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is MTVA Expensive or Cheap?

P/E Ratio

MTVA trades at -0.22 times earnings. This suggests potential undervaluation.

-0.22

PEG Ratio

When adjusting for growth, MTVA's PEG of -0.01 indicates potential undervaluation.

-0.01

Price to Book

The market values MetaVia Inc. at 0.52 times its book value. This may indicate undervaluation.

0.52

EV/EBITDA

Enterprise value stands at -0.95 times EBITDA. This is generally considered low.

-0.95

How Well Does MTVA Make Money?

Net Profit Margin

For every $100 in sales, MetaVia Inc. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-2.02 in profit for every $100 of shareholder equity.

-2.02%

ROA

MetaVia Inc. generates $-18.77 in profit for every $100 in assets, demonstrating efficient asset deployment.

-18.77%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-6.80 in free cash annually.

$-6.80

FCF Yield

MTVA converts -5.94% of its market value into free cash.

-5.94%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.22

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.52

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.04

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.93

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-2.02

vs 25 benchmark

ROA

Return on assets percentage

-0.19

vs 25 benchmark

ROCE

Return on capital employed

-0.22

vs 25 benchmark

How MTVA Stacks Against Its Sector Peers

MetricMTVA ValueSector AveragePerformance
P/E Ratio-0.2227.91 Better (Cheaper)
ROE-202.17%687.00% Weak
Net Margin0.00%-45285.00% (disorted) Weak
Debt/Equity0.040.33 Strong (Low Leverage)
Current Ratio1.932795.76 Neutral
ROA-18.77%-13557.00% (disorted) Weak

MTVA outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews MetaVia Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

99.64%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

99.01%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ